Carcinosinumproduces phenotypic changes of 4T1 tumor cells in vitro
Int. j. high dilution res; 21 (1), 2022
Considering that there are few published studies that specifically address the exclusive use of Carcinosinumin different potencies and, most of them focused on genotypic and clinical effects, the present study was proposed to identify possible phenotypic changes, including viability, express...